Literature DB >> 2983595

Primary Sjögren's syndrome after infectious mononucleosis.

S Whittingham, J McNeilage, I R Mackay.   

Abstract

A healthy young woman developed primary Sjögren's syndrome after protracted infectious mononucleosis. The diagnosis of primary Sjögren's syndrome was supported by histologic evidence of sialadenitis in labial salivary glands, rheumatoid factor, hypergammaglobulinemia, the HLA-B8 phenotype, and a high titer antibody to the anti-La (SS-B) nucleoprotein that co-precipitated the small ribonucleic acids encoded by Epstein-Barr virus, EBER 1 and EBER 2, as well as "host" RNA. There was strong humoral immunity to the Epstein-Barr nuclear and capsid antigens, but weak T-lymphocyte-mediated cytotoxicity to Epstein-Barr-transformed lymphoblasts, anergy to antigens used to elicit delayed-type hypersensitivity, and a low T-helper/T-suppressor cell ratio. The series of events initiated by infectious mononucleosis was attributed to a genetic defect in the immune response. Association of viral RNA with the La nucleoprotein resulted in a break in immunologic tolerance via a T-cell bypass effect with induction of anti-La (SS-B) by polyclonally activated B lymphocytes leading to autoimmune sialadenitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983595     DOI: 10.7326/0003-4819-102-4-490

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

1.  Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study.

Authors:  Yasuhiro Horiuchi; Junichi Hakugawa; Kazuhiro Shimizu; Ichiro Katayama; Tomayoshi Hayashi; Masahiro Kikuchi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

Review 2.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Association of Epstein-Barr virus (EBV) with Sjögren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands.

Authors:  S Wen; N Shimizu; H Yoshiyama; Y Mizugaki; F Shinozaki; K Takada
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome.

Authors:  P J Venables; C G Teo; C Baboonian; B E Griffin; R A Hughes
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

Review 5.  Reactivation of Epstein-Barr virus in Sjögren's syndrome.

Authors:  R I Fox; M Luppi; H I Kang; P Pisa
Journal:  Springer Semin Immunopathol       Date:  1991

6.  Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome.

Authors:  S C Pflugfelder; C A Crouse; D Monroy; M Yen; M Rowe; S S Atherton
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein.

Authors:  H Kohsaka; K Yamamoto; H Fujii; H Miura; N Miyasaka; K Nishioka; T Miyamoto
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

8.  Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus.

Authors:  K Xie; M Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.

Authors:  I S Misko; C Schmidt; M Honeyman; T D Soszynski; T B Sculley; S R Burrows; D J Moss; K Burman
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

10.  Molecular analysis of the RNA and protein components recognized by anti-La(SS-B) autoantibodies.

Authors:  L J McNeilage; S Whittingham; I Jack; I R MacKay
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.